NOD-like receptor signaling pathway |
178 |
16.9 |
33 |
0.000121 |
0.0318 |
Pertussis |
76 |
7.21 |
18 |
2.00E-04 |
0.0318 |
Autophagy - animal |
128 |
12.1 |
24 |
0.000836 |
0.0886 |
Leishmaniasis |
74 |
7.02 |
16 |
0.00129 |
0.102 |
IL-17 signaling pathway |
93 |
8.82 |
18 |
0.0025 |
0.134 |
Lysosome |
123 |
11.7 |
22 |
0.00253 |
0.134 |
Amoebiasis |
96 |
9.11 |
18 |
0.00358 |
0.163 |
Calcium signaling pathway |
188 |
17.8 |
29 |
0.00573 |
0.228 |
TNF signaling pathway |
110 |
10.4 |
19 |
0.00711 |
0.243 |
Influenza A |
167 |
15.8 |
26 |
0.00764 |
0.243 |
Complement and coagulation cascades |
79 |
7.49 |
14 |
0.0156 |
0.427 |
Phagosome |
152 |
14.4 |
23 |
0.0161 |
0.427 |
Pentose phosphate pathway |
30 |
2.85 |
7 |
0.0197 |
0.481 |
PI3K-Akt signaling pathway |
354 |
33.6 |
45 |
0.0247 |
0.505 |
Staphylococcus aureus infection |
68 |
6.45 |
12 |
0.0248 |
0.505 |
HIF-1 signaling pathway |
100 |
9.49 |
16 |
0.0254 |
0.505 |
Apoptosis |
136 |
12.9 |
20 |
0.0313 |
0.538 |
Legionellosis |
55 |
5.22 |
10 |
0.0321 |
0.538 |
AMPK signaling pathway |
120 |
11.4 |
18 |
0.0334 |
0.538 |
EGFR tyrosine kinase inhibitor resistance |
79 |
7.49 |
13 |
0.0338 |
0.538 |
Measles |
138 |
13.1 |
20 |
0.0358 |
0.539 |
Epstein-Barr virus infection |
201 |
19.1 |
27 |
0.0398 |
0.539 |
Mitophagy - animal |
65 |
6.17 |
11 |
0.0406 |
0.539 |
Endocrine resistance |
98 |
9.3 |
15 |
0.0422 |
0.539 |
Cell cycle |
124 |
11.8 |
18 |
0.0442 |
0.539 |
Cellular senescence |
160 |
15.2 |
22 |
0.0478 |
0.539 |
DNA replication |
36 |
3.42 |
7 |
0.0493 |
0.539 |